Escherichia coli in Poultry: Zoonotic Transmission, Clinical Manifestations, and Control Strategies
Etiology and Classification
Escherichia coli is a Gram-negative, facultative anaerobic bacillus belonging to the family Enterobacteriaceae. In poultry, strains are broadly categorized as avian pathogenic E. coli (APEC), which cause colibacillosis, and commensal strains that reside in the intestinal tract [1, 2]. APEC strains are distinguished by the presence of specific virulence-associated genes (VAGs) that facilitate adhesion, invasion, and evasion of the host immune response [3, 4]. The serogroups most commonly associated with avian disease include O1, O2, O78, and O18 [5]. Genomic profiling of APEC isolates has revealed a diverse array of pathogenicity islands, plasmids encoding virulence factors, and antibiotic resistance determinants [6, 7]. The O78 serogroup is frequently implicated in severe outbreaks and is a model strain in experimental pathogenesis studies [8, 9]. The ecnAB toxin-antitoxin system modulates APEC virulence by regulating the capsular sialic acid biosynthesis pathway [9]. The presence of the iroN virulence gene, encoding a catecholate siderophore receptor, is associated with multidrug resistance in isolates from quail and other poultry species [10]. The quorum-sensing regulator LsrR modulates resistance to oxidative stress by interfering with sulfate assimilation in APEC [11]. The small regulatory RNAs RyfA and TimR orchestrate stress resistance and virulence in APEC [12]. The complete genomes of APEC isolates from colibacillosis cases have been sequenced, enabling detailed comparative genomic analyses [5].
Epidemiology and Prevalence
E. coli is ubiquitous in poultry production environments and can be isolated from feces, feed, water, litter, and dust [13]. The prevalence of APEC in commercial poultry operations varies widely depending on management practices, biosecurity levels, and geographic region [1]. Studies in West Kazakhstan have documented high occurrence rates of E. coli in commercial poultry farms [1]. In Bangladesh, multidrug resistant E. coli is disseminated across one health interfaces [13]. Poultry flocks in Kenya show distinct antimicrobial resistance profiles for E. coli and Campylobacter species [14]. In Vietnam, a high prevalence of atypical enteropathogenic E. coli (aEPEC) contaminating retail chicken meat has been reported [15]. In China, mcr-1-positive colistin-resistant E. coli strains (ST162, ST93, and ST3941) persist in poultry farms and have been characterized over multiple years [16, 17]. In Algeria, these clones have persisted over time [17]. In the Netherlands, OXA-244 carbapenemase-producing E. coli has been detected in farm animals [18]. In Egypt, expanded spectrum beta-lactamase (ESBL) producing E. coli has been isolated from chickens with colibacillosis [19]. In Brazil, temperate bacteriophages and associated genetic features have been characterized in APEC isolates [20]. In Mozambique, strain level analyses of public sequencing data have characterized E. coli strain sharing between children and chickens [21].
Ground Chicken Bacteria and Outbreak Dynamics
A frequent question in public health is "can you get e coli from chicken?" The answer is affirmative, and the term "ground chicken bacteria" refers to pathogens that contaminate ground poultry products during processing. A "chicken bacteria outbreak" linked to E. coli typically involves contamination at the slaughter or processing stage [15, 22]. Ground chicken is a high-risk product because grinding increases surface area and distributes bacteria throughout the meat [22]. Retail chicken meat contamination with ESBL-producing and carbapenem resistant E. coli has been documented in Bangladesh [23]. In Argentina, high priority critically important antimicrobial resistant E. coli has been isolated from pork and chicken retail meat [22]. In Brazil, APEC genomes have been sequenced from colibacillosis cases [5].
Pathogenesis and Virulence Mechanisms
The pathogenesis of colibacillosis begins with the inhalation or ingestion of E. coli, followed by colonization of the upper respiratory tract or intestine [24]. APEC can interact directly with H9N2 avian influenza virus, which promotes bacterial adhesion during co-infections [24]. Following colonization, bacteria translocate across epithelial barriers and enter the bloodstream [12]. The luxS gene facilitates environmental adaptability and competition capability of APEC [25].
Virulence factors of APEC include fimbrial adhesins (F1, P, and curli fimbriae), flagella, toxins (hemolysin, cytotoxic necrotizing factor, and enteroaggregative heat-stable toxin 1), iron acquisition systems (aerobactin, salmochelin, and yersiniabactin), and lipopolysaccharide [2, 3]. The capsular polysaccharide, particularly group I capsules like K1, is critical for serum resistance [9]. The quorum sensing regulator LsrR modulates resistance to oxidative stress [11].
Clinical Manifestations
The clinical presentation of colibacillosis depends on the age of the bird, the route of infection, and the virulence of the strain [8]. Respiratory colibacillosis, also known as airsacculitis, is common in broilers and is often secondary to viral infections such as infectious bronchitis virus or Newcastle disease virus [24]. The disease progresses from tracheitis to airsacculitis, pericarditis, perihepatitis, and peritonitis [8]. Septicemic colibacillosis is an acute, rapidly fatal condition characterized by depression, anorexia, fever, cyanosis, and sudden death [9]. Localized infections include omphalitis (yolk sac infection) in young chicks, cellulitis (necrotizing dermatitis primarily affecting the thighs and abdomen), salpingitis (inflammation of the oviduct) in laying hens, and synovitis/arthritis [1, 26, 3]. Swollen head syndrome, characterized by periorbital and infraorbital sinus swelling, is associated with APEC infection combined with respiratory viral agents [24, 8, 27]. Birds may also present with diarrhea, decreased feed and water intake, and decreased egg production.
For detailed descriptions of clinical signs, see the related articles Escherichia coli Infections in Poultry: Colibacillosis, Zoonotic Risk, and Control and Chicken E. coli Symptoms: Clinical Manifestations of Avian Pathogenic Escherichia coli.
Pathology
Gross pathological findings in colibacillosis include fibrinous pericarditis (thickened, opaque pericardium with yellow fibrin), perihepatitis (fibrinous exudate covering the liver surface), airsacculitis (thickened, cloudy air sacs with caseous exudate), peritonitis (fibrinous exudate and free fluid in the abdominal cavity), and salpingitis (distended oviduct with caseous exudate) [26, 8]. In septicemic cases, the spleen and liver are enlarged and congested [9]. Omphalitis presents as a swollen, discolored yolk sac with caseous contents [1]. Cellulitis is characterized by subcutaneous yellowish, caseous plaques that extend between the skin and muscle [3].
Histopathology reveals severe inflammation with fibrin deposition, heterophil infiltration, and necrosis in affected tissues [8]. The capsule of APEC is thick and protects the bacteria from phagocytosis [9].
Diagnostic Approaches
Bacteriological Culture
Isolation of E. coli is performed by plating clinical samples (liver, spleen, heart blood, air sac exudate, yolk sac) on MacConkey agar or eosin methylene blue (EMB) agar [1, 22]. Typical colonies are lactose-fermenting (pink on MacConkey, metallic green sheen on EMB). Gram staining shows Gram-negative rods. Biochemical confirmation includes positive reactions for indole production, methyl red, and lysine decarboxylase, with negative reactions for Voges-Proskauer and citrate utilization [1].
Molecular Diagnostics
Polymerase chain reaction (PCR) assays target species-specific genes (e.g., uidA, phoA) and virulence-associated genes (e.g., iroN, iss, iutA, hlyF, ompT, papC, cvi/cva) [3, 15, 10]. Multiplex PCR panels enable pathotyping and detection of antimicrobial resistance genes such as blaCTX-M, blaTEM, blaSHV, and mcr-1 [6, 18, 28]. Whole genome sequencing (WGS) provides comprehensive genomic characterization, including multilocus sequence typing (MLST), plasmid replicon typing, and detection of CRISPR-Cas systems [6, 2, 4, 5, 7]. The workflow for WGS-based characterization is illustrated in the following diagram.
flowchart TD
A[Clinical Sample: Liver, Spleen, Yolk Sac], > B[DNA Extraction]
B, > C[Library Preparation and Sequencing]
C, > D[Quality Filtering and Assembly]
D, > E[Bacterial Identification via k-mer or 16S]
E, > F[Serotyping in silico]
F, > G[Virulence Gene Detection]
G, > H[MLST / cgMLST]
H, > I[Antimicrobial Resistance Gene Detection]
I, > J[Plasmid Replicon Typing]
J, > K[Phylogenetic Analysis]
K, > L[Report: Pathotype, Resistance Profile, ST]
Serological and Other Assays
Serotyping is performed using antisera against O (somatic) and H (flagellar) antigens [5]. Commercial ELISA kits targeting APEC-specific antigens are used for serological surveillance at the flock level [29, 27]. Automated biochemical panels can identify E. coli to the species level [1].
Antimicrobial Resistance
Antimicrobial resistance (AMR) in poultry E. coli is a global One Health concern [2, 28, 13]. Resistome analysis of ESBL/AmpC producing E. coli from backyard poultry has identified a wide array of beta-lactamase genes including blaCTX-M, blaTEM, and blaSHV [6, 19]. The mcr-1 gene conferring colistin resistance has been detected in poultry isolates from China, Algeria, and Bangladesh [16, 17, 23]. Carbapenemase genes such as blaOXA-244 have been reported in Dutch farm animals [18]. Fluoroquinolone resistance is common, mediated by mutations in gyrA and parC and by plasmid-mediated qnr genes [1, 4]. Aminoglycoside resistance genes (aac, aad, str) and tetracycline resistance genes (tetA, tetB) are prevalent [28, 13]. Multidrug resistance (MDR) defined as resistance to three or more antimicrobial classes is frequently reported [2, 4, 22].
Antimicrobial Stewardship
Prudent antimicrobial use in poultry production is critical to mitigate AMR [14, 30]. The use of antimicrobials classified as critically important for human medicine (e.g., fluoroquinolones, third-generation cephalosporins, colistin) should be restricted [18, 23]. Alternatives to conventional antimicrobials include probiotics and their metabolites, which inhibit APEC growth and suppress virulence factor expression [31]. Bacteriophage therapy targeting APEC is under development, with temperate phages identified in Brazilian isolates [20]. Antimicrobial peptides identified by artificial intelligence have been evaluated for efficacy and safety in broilers [32]. Plant-derived compounds such as polyphenols from Myrmecodia sp. [26] and Piper betle L. extract in deep eutectic solvent emulsions [33] show promise in reducing APEC colonization and biofilm formation on stored chicken meat [33]. A polysaccharide from Atractylodes macrocephala protects against APEC-induced intestinal barrier dysfunction [34]. The herb pair extract of Ilex rotunda Thunb. and Cyperus rotundus L. has shown preventive effects on avian colibacillosis [35]. The traditional Chinese medicine Sihuang Zhili Granules protects against APEC O78 challenge through gut homeostasis related changes [8].
Treatment
Treatment of colibacillosis in poultry is based on antimicrobial therapy guided by culture and susceptibility testing [1, 14]. Commonly used antimicrobials include amoxicillin, trimethoprim sulfonamide combinations, tetracyclines, and fluoroquinolones, although resistance is widespread [1, 28, 14]. Supportive care includes optimizing ventilation to reduce ammonia levels, reducing stocking density, and correcting nutritional deficiencies [8]. For localized infections like omphalitis, administration of antimicrobials via drinking water or injection is common [1].
Control Strategies
Biosecurity
Biosecurity measures are the primary line of defense against APEC introduction and spread [1, 13]. All-in/all-out production, cleaning and disinfection between flocks, control of rodents and wild birds, and chlorination of drinking water are essential [1, 13]. Footbaths and dedicated protective clothing for personnel reduce horizontal transmission [13].
Vaccination
Autogenous (farm-specific) bacterins are used widely, though their efficacy varies [29]. Epitope-based and peptide-based vaccines against APEC have been analyzed in a meta-analysis with machine learning insights [29]. Biomimetic vesicles displaying the H9 subtype avian influenza virus HA1 protein on an E. coli outer membrane scaffold have been constructed as a bivalent vaccine platform [27].
Probiotics and Prebiotics
Probiotic metabolites exhibit antimicrobial activity and inhibit APEC virulence factors [31]. Probiotics are often administered in feed or water, particularly during the first week of life when chicks are most susceptible [31].
Environmental Control
Litter management is critical. Wet litter promotes bacterial proliferation [1]. Deep litter systems require periodic turning and removal. Drinking water should be treated with disinfectants such as chlorine or organic acids [1]. Air filtration and negative pressure ventilation in hatcheries reduce airborne transmission [13].
Food Safety Interventions
To answer the question "can you get e coli from chicken," the answer is yes, primarily through cross-contamination in the kitchen. "Ground chicken bacteria" is a specific risk because grinding distributes bacteria. A "chicken bacteria outbreak" is typically associated with undercooked meat or improper handling. Interventions at the processing level include carcass washing with organic acids (e.g., lactic acid, peracetic acid), irradiation, and heat treatment [22, 30]. Liposomal formulations of cinnamon, oregano, and clove essential oils have been used to control virulent ESBL-producing E. coli in meat [30]. A deep eutectic solvent-based emulsion containing Piper betle extract prevents biofilm development of APEC on stored chicken meat [33].
Zoonotic Transmission and Public Health
Zoonotic transmission of E. coli from poultry to humans occurs primarily through the foodborne route, specifically the handling or consumption of contaminated meat or eggs [2, 15, 21]. The question "can you get e coli from chicken" is answered affirmatively by numerous studies [15, 23]. "Ground chicken bacteria" refers to the contamination of ground poultry products, which can harbor APEC and other pathogenic E. coli strains [22]. A "chicken bacteria outbreak" related to E. coli is frequently traced to undercooked ground chicken or cross-contamination in domestic kitchens [22]. Direct contact with live poultry or contaminated environments (e.g., backyard flocks, live bird markets) also poses a risk [21, 23]. Molecular epidemiology studies using WGS have demonstrated strain sharing between poultry and humans, confirming zoonotic transmission [21].
Summary of Key Points
| Aspect | Key Information | References |
|---|---|---|
| Etiology | Avian pathogenic E. coli (APEC), serogroups O1, O2, O78, O18 | [1, 3, 4, 5] |
| Transmission routes | Inhalation, ingestion, vertical (via egg), horizontal (fecal-oral), contact with contaminated environments | [24, 1, 13] |
| Clinical manifestations in poultry | Respiratory disease (airsacculitis), septicemia, omphalitis, cellulitis, salpingitis, swollen head syndrome | [1, 26, 3, 8, 9] |
| Food safety risk | Contamination of retail ground chicken and chicken meat | [15, 22, 23, 30] |
| Diagnostic methods | Culture on MacConkey/EMB agar, PCR for virulence/AMR genes, WGS | [6, 1, 15, 5, 7, 10] |
| Control measures | Biosecurity, antimicrobial stewardship, vaccination, probiotics, plant extracts | [35, 29, 8, 32, 31] |
Conclusion
Escherichia coli remains a significant pathogen in poultry production, causing substantial economic losses and posing zoonotic risks. The emergence of multidrug-resistant and ESBL-producing strains, including those resistant to colistin and carbapenems, underscores the urgency of integrated control strategies. A One Health approach combining enhanced biosecurity, prudent antimicrobial use, vaccination, and novel intervention technologies is essential to mitigate the impact of APEC on both animal and public health.
References
[1] Dushayeva L, Murzabayev K, Karagulov A, et al. Occurrence and Antimicrobial Resistance Profiles of Escherichia coli Isolated from Commercial Poultry Farm in West Kazakhstan. Biology (Basel). 2026.
[2] Masum MHU, Chamonara K, Uddin MS, et al. Comprehensive genomic analysis of avian Escherichia coli from Noakhali uncovers multidrug resistance, metal resistance, and zoonotic signatures. Sci Rep. 2026.
[3] Huang J, Hu M, Song L, et al. Comparative genomic analysis of antimicrobial resistance and virulence in Escherichia coli isolated from pigeons and chickens in live poultry markets, Guiyang, China. Poult Sci. 2026.
[4] Ni W, Chen L, Chen H, et al. Genomic and Pathogenic Characterization of an Extensively Drug-Resistant Avian Pathogenic Escherichia coli Strain. Transbound Emerg Dis. 2026.
[5] Runcharoon K, Ienes-Lima J, Logue CM. Complete genomes of 21 avian pathogenic Escherichia coli isolated from colibacillosis cases in Georgia poultry. Microbiol Resour Announc. 2026.
[6] Nagaraja PK, Mitra SD, Murugesan D, et al. Genomic profiling of ESBL/AmpC-producing Escherichia coli from backyard poultry: resistome, virulome, plasmidome, and CRISPR-Cas insights. Front Microbiol. 2026.
[7] Gaonkar PP, Golden R, Santana-Pereira ALR, et al. Genomic characterization of avian pathogenic Escherichia coli and its potential as a marker organism for antimicrobial resistance. Appl Environ Microbiol. 2026.
[8] Guo Z, Wang X, Cai D, et al. Integrative analysis of 16S rRNA sequencing and network pharmacology suggests protective effects of Sihuang Zhili Granules against APEC O78 challenge through gut homeostasis-related changes. Front Vet Sci. 2026.
[9] Jing Y, Shen X, Yin D, et al. The ecnAB toxin-antitoxin system modulates avian pathogenic Escherichia coli virulence through regulating the capsular sialic acid biosynthesis pathway. Vet Microbiol. 2026.
[10] Keytimu MO, Rahayu U, Wibisono FJ, et al. Detection of the iroN virulence gene in multidrug-resistant Escherichia coli isolated from quails in traditional markets of Surabaya, Indonesia. Vet World. 2026.
[11] Kong L, Tu C, Song X, et al. Quorum-sensing regulator LsrR modulates resistance to oxidative stress by interfering with sulfate assimilation in avian pathogenic Escherichia coli. J Bacteriol. 2026.
[12] Anamalé C, Bessaiah H, Ng Kwan Lim E, et al. Orchestrating infection: the impact of RyfA and TimR sRNAs on stress resistance and virulence in avian pathogenic Escherichia coli in chickens. Appl Environ Microbiol. 2026.
[13] Rahman A, Roy S, Afreen N, et al. Environmental dissemination of multidrug-resistant Escherichia coli across one health interfaces in Mymensingh, Bangladesh. NPJ Antimicrob Resist. 2026.
[14] Mbindyo CM, Achieng LA, Wanja DW, et al. Antimicrobial use and resistance profiles of Escherichia coli and Campylobacter species from small-scale poultry farms in Central Kenya. BMC Vet Res. 2026.
[15] Le YH, Hoang HTT, Khong DT, et al. High prevalence of atypical enteropathogenic Escherichia coli contaminating retail chicken meat in Vietnam: virulence gene profiles, sequence types, and antimicrobial resistance. J Infect Chemother. 2026.
[16] Xu J, Yan B, Fu Q, et al. Prevalence and Genomic Characterization of mcr-1-Positive Escherichia coli from Livestock in Hunan Province, China (2016-2021). Curr Microbiol. 2026.
[17] Kirat H, Barraud O, Rahab H, et al. Persistence of MCR-1-Positive Colistin-Resistant E. coli ST162, ST93, and ST3941 Clones in Poultry Farms, Algeria. Microb Drug Resist. 2026.
[18] Veldman KT, van Essen-Zandbergen A, Geurts Y, et al. Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024. J Antimicrob Chemother. 2026.
[19] El-Shazly DA, Nasef SA, Mahmoud FF, et al. Corrigendum to "Expanded spectrum β-lactamase producing Escherichia coli isolated from chickens with colibacillosis in Egypt" [Poultry Science, Volume 96, Issue 7, 2375-2384]. Poult Sci. 2026.
[20] Cadamuro RD, Pilati GVT, Elois MA, et al. Genome Characterization of Temperate Bacteriophages and Associated Genetic Features in Avian Pathogenic Escherichia coli from Brazilian Poultry. Animals (Basel). 2026.
[21] Olson N, Thystrup CAN, Smith F, et al. Strain-level analyses of public sequencing data to characterize Escherichia coli strain sharing between children and chickens in Mozambique. One Health. 2026.
[22] Nievas HD, Aurnague C, Helman E, et al. Genomic Diversity and Virulence Potential of High-Priority Critically Important Antimicrobial-Resistant Escherichia coli from Pork and Chicken Retail Meat. Pathogens. 2026.
[23] Parvin MS, Talukder S, Sharmy ST, et al. Distribution of ESBL-producing and carbapenem-resistant E. coli and Salmonella spp. in retail chicken meat and live bird market sewage in Bangladesh. PLoS One. 2026.
[24] Li Y, Xue Y, Quan Y, et al. Direct interaction between avian pathogenic Escherichia coli and H9N2 avian influenza virus promotes bacterial adhesion during their infections. Microbiol Spectr. 2026.
[25] Liu C, Hu J, Guo M, et al. LuxS facilitates environmental adaptability and competition capability of avian pathogenic Escherichia coli. Poult Sci. 2026.
[26] Lisnanti EF, Lokapirnasari WP, Arif MAA, et al. Comparative effects of Myrmecodia sp. extract and infusion on organ function biomarkers, lipid metabolism, and meat lipid profile in avian pathogenic Escherichia coli-infected broiler chickens: Implications for sustainable poultry production within a One Health framework. Vet World. 2026.
[27] Li Y, Quan Y, Quan K, et al. Construction and immunogenicity evaluation of avian Escherichia coli-derived bacterial biomimetic vesicles displaying H9 subtype avian influenza virus HA1 protein. Vet Microbiol. 2026.
[28] de Souza Campos MR, Dias TS, Gonçalves VD, et al. Clinical and non-clinical Escherichia coli from chickens reveal antimicrobial resistance patterns of one health concern. Comp Immunol Microbiol Infect Dis. 2026.
[29] Waseem M, Kamran Z, Ali A. Advancing poultry health: A meta-analysis of epitope-based and peptide-based vaccines against Avian Pathogenic E. coli with machine learning insights. PLoS One. 2026.
[30] El-Hamid MIA, ELTarabili RM, Ibrahim GA, et al. Emergence of virulent ESBL-producing Escherichia coli in meat with human health implications and control using liposomal cinnamon, oregano, and clove within a One Health framework. Sci Rep. 2026.
[31] Thapa K, Phan A, Tung CW, et al. Evaluation of Probiotic Metabolites Mediated Antimicrobial Activity and Inhibition of Virulence Factors in Avian Pathogenic Escherichia Coli. Probiotics Antimicrob Proteins. 2026. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[32] Demirsoy E, Parkin TI, Mihalynuk SE, et al. Efficacy and safety evaluation of artificial intelligence-identified antimicrobial peptides targeting avian pathogenic Escherichia coli in broiler chickens. J Anim Sci Biotechnol. 2026.
[33] Ratchasong K, Saengsawang P, Yusakul G, et al. Deep Eutectic Solvent-Based Emulsion Containing Piper betle L. Extract and Hydroxychavicol Prevent Biofilm Development and Surface Adhesion of Avian Pathogenic Escherichia coli on Stored Chicken Meat. Antibiotics (Basel). 2026.
[34] Chen S, Qu X, Wu J. Polysaccharide from Atractylodes macrocephala Koidz. protects against avian pathogenic Escherichia coli-induced intestinal barrier Dysfunction via Suppressing PI3K/Akt-Mediated Claudin-2 upregulation. Poult Sci. 2026.
[35] Liu H, Yang A, Wei X, et al. Preventive effects and underlying mechanisms of Ilex rotunda Thunb.-Cyperus rotundus L. herb pair extract on avian colibacillosis in chickens. Poult Sci. 2026.